Add to ORKGMost important value of lowering of substantially elevated arterial pressure (AP) for improvement of outcomes in patients with arterial hypertension (AH) was convincingly confirmed by large truly placebo controlled randomized clinical trials (RCT) with the use of mainly diuretics, and/or (i-adrenoblockers in the 6O-80ths. Later comparative RCT confirmed equal antihypertensive efficacy of 5 main drug classes relative to AP level in brachial artery. In this review we discuss merit of auxiliary class-specific properties of antihypertensive agents potentially affecting prognosis besides AP lowering. We also discuss problems related to decline of significance of quantitative criteria of AH and consideration of AP level in general context of card...
Background: Blood pressure lowering drugs are usually evaluated in short term trials determining the...
BACKGROUND: Whether antihypertensive drugs offer cardiovascular protection beyond blood pressure low...
In 2002, a major topic of discussion in the field of clinical hypertension was the efficacy of the v...
Most important value of lowering of substantially elevated arterial pressure (AP) for improvement of...
In a quantitative overview of published trials, we investigated whether pharmacologic properties of ...
Arterial hypertension is a widely prevalent risk factor for cardiovascular diseases with well docume...
The pharmacologic treatment of hypertension has been extensively studied by clinical trials. These s...
The aim of the treatment of hypertensive disease is to reduce its associated cardiovascular morbidit...
Blood pressure reduction represents a key priority for any preventive strategy in hypertension. Howe...
The aim of the treatment of hypertensive disease is to reduce its associated cardiovascular morbidit...
<p>Arterial hypertension (HT) takes leading position in the structure of morbidity and mortality amo...
In 2002, a major topic of discussion in the field of clinical hypertension was the efficacy of the v...
In 2002, a major topic of discussion in the field of clinical hypertension was the efficacy of the v...
All major antihypertensive drug classes i.e. diuretics, beta-blockers, calcium antagonists and block...
<p>Arterial hypertension (HT) takes leading position in the structure of morbidity and mortality amo...
Background: Blood pressure lowering drugs are usually evaluated in short term trials determining the...
BACKGROUND: Whether antihypertensive drugs offer cardiovascular protection beyond blood pressure low...
In 2002, a major topic of discussion in the field of clinical hypertension was the efficacy of the v...
Most important value of lowering of substantially elevated arterial pressure (AP) for improvement of...
In a quantitative overview of published trials, we investigated whether pharmacologic properties of ...
Arterial hypertension is a widely prevalent risk factor for cardiovascular diseases with well docume...
The pharmacologic treatment of hypertension has been extensively studied by clinical trials. These s...
The aim of the treatment of hypertensive disease is to reduce its associated cardiovascular morbidit...
Blood pressure reduction represents a key priority for any preventive strategy in hypertension. Howe...
The aim of the treatment of hypertensive disease is to reduce its associated cardiovascular morbidit...
<p>Arterial hypertension (HT) takes leading position in the structure of morbidity and mortality amo...
In 2002, a major topic of discussion in the field of clinical hypertension was the efficacy of the v...
In 2002, a major topic of discussion in the field of clinical hypertension was the efficacy of the v...
All major antihypertensive drug classes i.e. diuretics, beta-blockers, calcium antagonists and block...
<p>Arterial hypertension (HT) takes leading position in the structure of morbidity and mortality amo...
Background: Blood pressure lowering drugs are usually evaluated in short term trials determining the...
BACKGROUND: Whether antihypertensive drugs offer cardiovascular protection beyond blood pressure low...
In 2002, a major topic of discussion in the field of clinical hypertension was the efficacy of the v...